Pavblu 55513-0065
Generic: Aflibercept-Ayyh
Product NDC
55513-0065- Manufacturer
- Amgen, Inc
- Dosage Form
- Injection, Solution
- Route
- Intravitreal
- Product Type
- Human Prescription Drug
- Marketing Start
- October 28, 2024
- Listing Expires
- December 31, 2027
- Application
- BLA761298
Need to source Pavblu? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Aflibercept | 2 mg/.05mL |
Drug Class
Vascular Endothelial Growth Factor Inhibitor [EPC]Vascular Endothelial Growth Factor Inhibitor [EPC]Vascular Endothelial Growth Factor Inhibitors [MoA]
Packaging Options(2)
1 VIAL in 1 CARTON (55513-065-01) / .05 mL in 1 VIAL
1 VIAL in 1 CARTON (55513-065-96) / .05 mL in 1 VIAL